Уноси

Covid-19, healthcare and self-medication issues in resource limited-settings : findings and implications based on experiences in Ghana (2021-09)

I. Sefah, D. Obeng Essah, M. Haque, S. Opanga, S. Kumar, I. Chikowe, D. Kibule, E. Rampambe, A. Kalungia, T. Phuong, Z. Saleem, V. Marković Peković, A. Kurdi, B. Godman, Covid-19, healthcare and self-medication issues in resource limited-settings : findings and implications based on experiences in Ghana, STED Journal, Vol. 11, No. 3, pp. 224 - 233, Sep, 2021
Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications (2021-10)

B. Godman, M. Wladysiuk, S. McTaggart, A. Kurdi, E. Allocati, M. Jakovljevic, F. Kalemeera, I. Hoxha, A. Nachtnebel, R. Sauremann, M. Hinteregger, V. Marković Peković, Б. Тубић, G. Petrova, K. Tachkov, J. Slaby, R. Nejezchlebova, I. Selke Krulichova, O. Laius, G. Selke, I. Langer, A. Harsanyi, A. Inotai, A. Jakupi, S. Henkuzens, K. Garuoliene, J. Gulbinovic, P. Vella Bonanno, J. Rutkowski, S. Ingeberg, O. Melien, I. Mardare, J. Furst, S. McBride-Stewart, C. Holmes, C. Pontes, C. Zara, M. Turu Pedrola, M. Hoffman, V. Kourafalos, A. Pisana, R. Banzi, S. Campbell, B. Wettermark, Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications, BioMed Research International, Vol. 2021, No. Article ID 99961, pp. 1 - 16, Oct, 2021
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications (2022-01)

Z. Saleem, B. Godman, F. Azhar, A. Kalungia, J. Fadare, S. Opanga, V. Marković Peković, I. Hoxha, A. Saeed, M. Al-Gethamy, A. Haseeb, M. Salman, A. Ali Khan, M. Umer Nadeem, I. Ur Rehman, M. Usman Qamar, A. Amir, A. Ikram, M. Azmi Hassali, Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications, EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, Vol. 20, No. 1, pp. 71 - 93, Jan, 2022
Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues (2022-03)

B. Godman, B. Tubić, E. Allocati, M. Wladysiuk, S. McTaggart, A. Kurdi, M. Haque, S. McBride-Stewart, F. Kalemeera, A. Massele, I. Hoxha, V. Marković Peković, G. Petrova, K. Tachkov, O. Laius, A. Harsanyi, A. Inotai, A. Jakupi, S. Henkuzens, K. Garuoliene, P. Vella Bonanno, J. Rutkowski, I. Mardare, J. Furst, C. Pontes, C. Zara, M. Turu Pedrola, F. Akter, H. Kwon, A. Martin, R. Banzi, J. Wale, J. Gulbinovic, Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues, Journal of Applied Pharmaceutical Science, Vol. 12, No. 3, pp. 055 - 072, Mar, 2022
First Experiences With the Use of Targeted and Immunotherapy in the Treatment of Cutaneous Melanoma: a Single Centre Experience (2022-03)

J. Berendika, S. Jungić, B. Tubić, I. Rakita, M. Vještica, D. Đokanović, Z. Gojković, N. Mirčeta, S. Petković, V. Marković Peković, First Experiences With the Use of Targeted and Immunotherapy in the Treatment of Cutaneous Melanoma: a Single Centre Experience, SCRIPTA MEDICA, Vol. 53, No. 1, pp. 29 - 35, Mar, 2022
Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up (2022-06)

D. Kalinić, R. Škrbić, D. Vulić, N. Stojaković, S. Stoisavljević-Šatara, M. Stojiljković, V. Marković Peković, A. Golić, N. Pilipović-Broćeta, N. Wong, B. Godman, Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up, Frontiers in Pharmacology, No. 889047, pp. 1 - 12, Jun, 2022
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries (2022-06)

A. Pisana, B. Wettermark, A. Kurdi, Б. Тубић, C. Pontes, C. Zara, E. Van Ganse, G. Petrova, I. Mardare, J. Furst, M. Roig-Izquierdo, O. Melien, P. Vella Bonanno, R. Banzi, V. Marković Peković, Z. Mitkova, B. Godman, Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries, Frontiers in Pharmacology, No. 873556, pp. 1 - 16, Jun, 2022
Public Pharmacies on the Territory of Bosnia and Herzegovina Over the Austro-Hungarian Rule (2022-09)

V. Marković Peković, Public Pharmacies on the Territory of Bosnia and Herzegovina Over the Austro-Hungarian Rule, SCRIPTA MEDICA, Vol. 53, No. 3, pp. 255 - 264, Sep, 2022
Trends in medicines utilization in Republic of Srpska, Bosnia and Herzegovina (2009-07)

V. Marković Peković, R. Škrbić, S. Stoisavljević-Šatara, Trends in medicines utilization in Republic of Srpska, Bosnia and Herzegovina, Basic & Clinical Pharmacology & Toxicology, Volume 105, Issue Supplement s1 Pages 1–164, pp. 92 - 92, Jul, 2009
Inﬂuence of Recent Initiatives in the Republic of Srpska to Improve Prescribing Efﬁciency; Inﬂuence and Future Direction (2012-08)

V. Marković Peković, B. Godman, R. Škrbić, V. Vlahović-Palčevski, L. Gustafsson, Inﬂuence of Recent Initiatives in the Republic of Srpska to Improve Prescribing Efﬁciency; Inﬂuence and Future Direction, Pharmacoepidemiology and Drug Safety 2012; 21: (Suppl. 3), pp. 57 - 57, Aug, 2012
Essential To Review Health Policy Initiatives When Comparing Utilisation Patterns across Countries? (2012-08)

B. Godman, M. Bennie, S. Campbell, K. Garuoliene, M. Kalaba, V. Marković Peković, V. Vlahović-Palčevski, B. Wettermark, C. Zara, L. Gustafsson, Essential To Review Health Policy Initiatives When Comparing Utilisation Patterns across Countries?, Pharmacoepidemiology and Drug Safety Journal 2012; 21: (Suppl. 3), pp. 56 - 56, Aug, 2012
Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries (2016-11)

T. Bochenek, B. Godman, A. Bucsics, E. de Weerdt, J. Furst, E. Gailite, T. Hotvedt, I. Huys, A. Inotai, R. Joppi, A. Malaj, K. Margus, V. Marković Peković, S. Simoens, J. Slaby, L. Sović-Brkičić, E. Gurpinar, P. Vella Bonanno, E. Warminska, A. Pilc, Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries, Value in Health, Voulme 19, Issue 7, pp. A445 - A445, Nov, 2016
Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries (2017-11)

I. Hoxha, A. Malaj, B. Kraja, S. Bino, M. Oluka, V. Marković Peković, B. Godman, Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries, Abstract Book, pp. 60 - 60, Nov, 2017
The Implementation of managed entry agreements in Central and Eastern Europe: Findings and implications for future policies (2017-11)

A. Ferrario, D. Araja, T. Bochenek, T. Catic, M. Dimitrova, J. Furst, L. Greičiute-Kuprijanov, I. Hoxha, E. Laidmae, O. Loblova, I. Mardare, V. Marković Peković, D. Meshkov, P. Kanavos, B. Godman, The Implementation of managed entry agreements in Central and Eastern Europe: Findings and implications for future policies, Abstract Book, pp. 49 - 49, Nov, 2017
Antibiotic utilization in the Republic of Srpska – initiatives, their influence and implications. (2017-11)

L. Bojanić, V. Marković Peković, Р. Шкрбић, М. Ђермановић, Ј. Бојанић, J. Furst, B. Godman, Antibiotic utilization in the Republic of Srpska – initiatives, their influence and implications., Abstract Book, pp. 63 - 63, Nov, 2017
Initiatives to reduce nonprescription sales and dispensing of antibiotics; findings and implications (2017-11)

V. Marković Peković, N. Grubiša, L. Bojanić, B. Godman, Initiatives to reduce nonprescription sales and dispensing of antibiotics; findings and implications, Abstract Book, pp. 65 - 65, Nov, 2017
Eight-year study of antibiotic utilization in the Republic of Srpska (2010-2017 years); findings and implications (2020-03)

М. Ђермановић, V. Marković Peković, Љ. Бојанић, B. Godman, K. Zrnić, Eight-year study of antibiotic utilization in the Republic of Srpska (2010-2017 years); findings and implications, Abstract Book, pp. 30 - 30, Mar, 2020
Политика унапређења здравља становништва Републике Српске до 2020. године (2012)

Р. Шкрбић, А. Лолић, В. Марковић Пековић, Љ. Лепир, М. Латиновић, Н. Милаковић, Политика унапређења здравља становништва Републике Српске до 2020. године, Зборник радова са научне конференције Република Српска двадесет година развоја - достигнућа, изазови и перспективе, pp. 337 - 352, 2012

Уноси

Covid-19, healthcare and self-medication issues in resource limited-settings : findings and implications based on experiences in Ghana (2021-09)

Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications (2021-10)

Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications (2022-01)

Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues (2022-03)

First Experiences With the Use of Targeted and Immunotherapy in the Treatment of Cutaneous Melanoma: a Single Centre Experience (2022-03)

Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up (2022-06)

Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries (2022-06)

Public Pharmacies on the Territory of Bosnia and Herzegovina Over the Austro-Hungarian Rule (2022-09)

Trends in medicines utilization in Republic of Srpska, Bosnia and Herzegovina (2009-07)

Inﬂuence of Recent Initiatives in the Republic of Srpska to Improve Prescribing Efﬁciency; Inﬂuence and Future Direction (2012-08)

Essential To Review Health Policy Initiatives When Comparing Utilisation Patterns across Countries? (2012-08)

Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries (2016-11)

Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries (2017-11)

The Implementation of managed entry agreements in Central and Eastern Europe: Findings and implications for future policies (2017-11)

Antibiotic utilization in the Republic of Srpska – initiatives, their influence and implications. (2017-11)

Initiatives to reduce nonprescription sales and dispensing of antibiotics; findings and implications (2017-11)

Eight-year study of antibiotic utilization in the Republic of Srpska (2010-2017 years); findings and implications (2020-03)

Политика унапређења здравља становништва Републике Српске до 2020. године (2012)